MxBiodevices LLC
Injectable wound repair scaffold for diabetic foot ulcers
This article was originally published in Start Up
Executive Summary
Despite the proliferation of advanced wound care products to treat diabetic foot ulcers, ranging from negative-pressure wound therapy to moist wound dressings and antimicrobials to artificial skin and growth factors, there has been minimal impact on clinical outcomes, according to MxBiodevices LLC. The start-up has already completed two human clinical trials of its injectable wound repair scaffold that is injected just under the wound surface to provide a healing structure.